Action(s) taken or orders passed

Date: 18th September, 2026 To, To, The Manager (Listing) Listing Compliance Department BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, Plot No. C/1, G Block, Dalal Street, Fort, Bandra-Kurla Complex, Mumbai - 400001 Bandra (E), Mumbai - 400051 BSE Scrip Code: 506260 NSE Symbol: ANUHPHR; Series: EQ Sub: Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI LODR’) Dear Sir/Madam, Pursuant to the provisions of Regulation 30 and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI LODR”), we hereby inform that the Income Tax Department (Assessment Unit) has issued a Notice of Demand Order under Section 156 of the Income Tax Act, 1961, against Anuh Pharma Limited. The said order has been passed in respect of the Assessment Year 2018-19 in relation to an Income Tax matter. The details, as required under Para A (20) of Part A of Schedule III to the SEBI LODR, are provided below: Sr. Particulars Details 1. Name of the Authority Income Tax Department, Assessment Unit 2. Nature and Details of the action(s) Demand Order under section 156 of the taken or order(s) passed Income Tax Act, 1961 passed for assessment year 2018-19, amounting to Rs. 9,93,206/- on account of disallowances deductions claimed. 3. Date of receipt of direction or order, 18th September, 2026 at IST 11:55 Hrs. including any ad-interim or interim orders, or any other communication from the authority 4. Details of the violation(s) / On account of disallowances of certain contravention(s) committed or deductions claimed under various alleged to be committed provision of the Income Tax Act. 5. Impact on financial, operation or The company is in process of filing an other activities of the listed entity, appeal before the CIT, against the said quantifiable in monetary terms to order within the prescribed timelines. The the extent possible Company believes that it has adequate factual and legal grounds to reasonably substantiate its position in the matter. As such, there is no impact on financial operations or other activities of the Company. You are requested to take note of the above. This disclosure is also being uploaded on the website of the Company at www.anuhpharma.com Thanking you, Yours faithfully, FOR ANUH PHARMA LIMITED MANAN VADHAN COMPANY SECRETARY & COMPLIANCE OFFICER Place: Mumbai